FOURTH LOAN MODIFICATION AGREEMENTLoan Modification Agreement • May 10th, 2006 • Critical Therapeutics Inc • Pharmaceutical preparations
This Fourth Loan Modification Agreement (this “Loan Modification Agreement”) is entered into as of January 6, 2006, by and between SILICON VALLEY BANK, a California-chartered bank, with its principal place of business at 3003 Tasman Drive, Santa Clara, California 95054 and with a loan production office located at One Newton Executive Park, Suite 200, 2221 Washington Street, Newton, Massachusetts 02462 (“Bank”) and CRITICAL THERAPEUTICS, INC., a Delaware corporation with its chief executive office located at 60 Westview Street, Lexington, Massachusetts 02421 (“Borrower”).
